Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies

Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies James W. Jakub, Solange Pendas, Douglas S. Reintgen Oncologist 2003; 8: 59-68 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in imaging and diagnostics and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Explain the current application of lymphatic mapping and sentinel lymph node biopsy. Discuss the ability of sentinel lymph node biopsy to allow a more focused pathologic evaluation and identify tumor cells not previously detected by standard techniques. Discuss the major controversies of lymphatic mapping and sentinel lymph node biopsy as they apply to melanoma, breast cancer, and colon cancer. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Feb. 24, 2003 Most Recent Review: October 13, 2005* Most Recent Update: Feb. 24, 2003 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.